Dietary antioxidants in preventing atherogenesis

Atherosclerosis

Volumn 187, Issue 1, 2006, Pages 1-17

  Kaliora, A C ^a   Dedoussis, G V Z ^a   Schmidt, H ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antioxidants; Atherosclerosis; Cardiovascular; Endothelial dysfunction; Gene regulation; LDL

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; FENOFIBRATE; FIBRINOLYTIC AGENT; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GROWTH FACTOR; HYDROXYTYROSOL; IRON; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN; LYCOPENE; OLEUROPEIN; OLIVE OIL; PHYTOSTEROL; POLYPHENOL; PROANTHOCYANIDIN DERIVATIVE; RESVERATROL; TYROSOL; UBIDECARENONE; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; XANTHINE OXIDASE INHIBITOR;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL CULTURE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ACTIVITY; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL MODEL; GENE CONTROL; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEREDITY; HOMEOSTASIS; HUMAN; HUMAN GENOME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; DIET; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; OXIDATIVE STRESS; OXYGEN; TRANSCRIPTION, GENETIC; VITAMINS;

EID: 33744513405     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.001     Document Type: Review

References (154)

1. Wattanapitayakul S.K., and Bauer J.A. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther 89 (2001) 187-206
2. Griendling K.K., and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 132 (1998) 9-15
3. Hiroi S., Harada H., Nishi H., et al. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with non-familial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 261 (1999) 332-339
4. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 91 (1995) 2488-2496
5. Houston M., Estevez A., Chumley P., et al. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. Biol Chem 274 (1999) 4985-4994
6. Brown J.F., Chafee K.A., and Tepperman B.L. Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon. Br J Pharmacol 123 (1998) 31-38
7. Castelli P., Condemi A.M., Brambillasca C., et al. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. Cardiovasc Pharmacol 25 (1995) 119-125
8. Bauersachs J., Bouloumie A., Fraccarollo D., et al. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100 (1999) 292-298
9. Sparagna G.C., and Hickson-Bick D.L. Cardiac fatty acid metabolism and the induction of apoptosis. Am J Med Sci 318 (1999) 15-21
10. Kacimi R., Karliner J.S., Koudssi F., et al. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res 82 (1998) 576-586
11. Stephens N.G., Parsons A., Schofield P.M., et al. Randomised controlled trial of Vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (1996) 781-786
12. Kritchevsky S.B., Shimakawa T., Tell G.S., et al. Dietary antioxidants and carotid artery wall thickness. The ARIC study. Atherosclerosis Risk in Communities study. Circulation 92 (1995) 2142-2150
13. Nyyssönen K., Parviainen M.T., Salonen R., et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. Br Med J 314 (1997) 634-638
14. Hertog M.G., Feskens E.J., Hollman P.C., et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly study. Lancet 342 (1993) 1007-1011
15. Street D.A., Comstock G.W., and Salkeld R.M. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and α0-tocopherol risk factors for myocardial infarction?. Circulation 90 (1994) 1154-1161
16. Kohlmeier L., Kark J.D., Gomez-Gracia E., et al. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146 (1997) 618-626
17. Bonithon-Kopp C., Coudray C., Berr C., et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 year. The EVA study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 65 (1997) 121-127
18. Gale C.R., Ashurst H.E., Powers H.J., and Martyn C.N. Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr 74 (2001) 402-408
19. Gianetti J., Pedrinelli R., Petrucci R., et al. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 143 (2002) 467-474
20. Aviram M., Rosenblat M., Gaitini D., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23 (2004) 423-433
21. Chait A., and Heinecke J.W. Lipoprotein modification: cellular mechanisms. Curr Opin Lipidol 5 (1994) 365-370
22. Napoli C., Triggiani M., Palumbo G., et al. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. Basic Res Cardiol 92 (1997) 96-105
23. Esterbauer H., Gebicki J., Herbert P., et al. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 13 (1992) 341-390
24. Shimozawa M., Naito Y., Manabe H., et al. 7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species. Redox Rep 9 6 (2004) 370-375
25. Stemme S., and Hansson G.K. Immune mechanisms in atherogenesis. Ann Med 26 (1994) 141-146
26. Andrikopoulos N.K., Kaliora A.C., Assimopoulou A.N., et al. Inhibitory activity of minor polyphenolic and non-polyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation. J Med Food 5 (2002) 1-7
27. Dieber-Rotheneder M., Puhl H., Waeg G., et al. Effect of oral supplementation with d-α-tocopherol on the Vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32 (1991) 1325-1332
28. Heitzer T., Yla Herttuala S., Wild E., et al. Effect of Vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol 33 (1999) 499-505
29. Palomaki A., Malminiemi K., Malminiemi O., et al. Effects of lovastatin therapy on susceptibility of LDL to oxidation during α-tocopherol supplementation. Arterioscler Thromb Vasc Biol 19 (1999) 1541-1548
30. Hodis H.N., Mack W.J., LaBree L., et al. α-Tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention study (VEAPS). Circulation 106 (2002) 1453-1459
31. Carpenter K.L., Kirkpatrick P.J., Weissberg P.L., et al. Oral α-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions. Free Radic Res 37 (2003) 1235-1244
32. Nagyova A., Mongiellova V., Krivosikova Z., et al. Serum ex vivo lipoprotein oxidizability in patients with ischemic heart disease supplemented with Vitamin E. Physiol Res 51 (2002) 457-464
33. van Tits L.J., de Waart F., Hak-Lemmers H.L., et al. Neutrophil superoxide-anion generating capacity in chronic smoking: effect of long-term alpha-tocopherol therapy. J Biosci 28 (2003) 23-27
34. Martin A., and Frei B. Both intracellular and extracellular Vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol 17 (1997) 1583-1590
35. Retsky K.L., Freeman M.W., and Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification: anti-rather than prooxidant activity of Vitamin C in the presence of transition metal ions. J Biol Chem 268 (1993) 1304-1309
36. Harats D., Chevion S., Nahir M., et al. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between Vitamins C and E in vivo. Am J Clin Nutr 67 (1998) 240-245
37. Yang M., Collis C.S., Kelly M., et al. Do iron and Vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers?. Eur J Clin Nutr 53 (1999) 367-374
38. Earnest C.P., Wood K.A., and Church T.S. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr 22 (2003) 400-407
39. McKechnie R., Rubenfire M., and Mosca L. Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease. J Lab Clin Med 139 (2002) 133-139
40. Samman S., Sivarajah G., Man J.C., et al. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 133 (2003) 2188-2193
41. Tesoriere L., Butera D., Pintaudi A.M., et al. Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with Vitamin C. Am J Clin Nutr 80 (2004) 391-395
42. Rice-Evans C.A., Miller N.J., and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20 (1996) 933-956
43. Aviram M., and Eias K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab 37 (1993) 75-84
44. Vissers M.N., Zock P.L., Wiseman S.A., et al. Effect of phenol-rich extra virgin olive oil on markers of oxidation in healthy volunteers. Eur J Clin Nutr 55 (2001) 334-341
45. O'Byrne D.J., Devaraj S., Grundy S.M., et al. Comparison of the antioxidant effects of Concord grape juice flavonoids α-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76 (2002) 1367-1374
46. Weisburger J.H. Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med 220 (1999) 271-275
47. O'Reilly J.D., Mallet A.I., McAnlis G.T., et al. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73 (2001) 1040-1044
48. Wan Y., Vinson J.A., Etherton T.D., et al. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74 (2001) 596-602
49. Chopra M., Fitzsimons P.E., Strain J.J., et al. Non-alcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. Clin Chem 46 (2000) 1162-11670
50. Jenkins D.J., Kendall C.W., Garsetti M., et al. Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity-a controlled crossover trial. Metabolism 49 (2000) 537-543
51. Steinberg F.M., Guthrie N.L., Villablanca A.C., et al. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78 (2003) 123-130
52. Sutherland W.H., Walker R.J., De Jong S.A., et al. Supplementation with tomato juice increases plasma lycopene but does not alter susceptibility to oxidation of low-density lipoproteins from renal transplant recipients. Clin Nephrol 52 (1999) 30-36
53. Carroll Y.L., Corridan B.M., and Morrissey P.A. Lipoprotein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers. Eur J Clin Nutr 54 (2000) 500-507
54. Hininger I.A., Meyer-Wenger A., Moser U., et al. No significant effects of lutein, lycopene or β-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr 20 (2001) 232-238
55. Agarwal S., and Rao A.V. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33 (1998) 981-984
56. Levy Y., Zaltsberg H., Ben-Amotz A., et al. Dietary supplementation of a natural isomer mixture of β-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann Nutr Metab 44 (2000) 54-60
57. Upritchard J.E., Sutherland W.H., and Mann J.I. Effect of supplementation with tomato juice, Vitamins E and C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diab Care 23 (2000) 733-738
58. Kaikkonen J., Nyyssonen K., Porkkala-Sarataho E., et al. Effect of oral coenzyme Q10 supplementation on the oxidation resistance of human VLDL + LDL fraction: absorption and antioxidative properties of oil and granule-based preparations. Free Radic Biol Med 22 (1997) 1195-1202
59. Kaikkonen J., Nyyssonen K., Tomasi A., et al. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-α-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study. Free Radic Res 33 (2000) 329-340
60. Kaikkonen J., Tuomainen T.P., Nyyssonen K., et al. Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free Radic Res 36 (2002) 389-397
61. Colette C., Pares-Herbute N., Monnier L.H., et al. Platelet function in type I diabetes: effects of supplementation with large doses of Vitamin E. Am J Clin Nutr 47 (1988) 256-261
62. Stampfer M.J., Jakubowski J.A., Faigel D., et al. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr 47 (1988) 700-706
63. Calzada C., Bruckdorfer K.R., and Rice-Evans C.A. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 128 (1997) 97-105
64. Jain S.K., Krueger K.S., McVie R., et al. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of Vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients. Diab Care 21 (1998) 1511-1516
65. de Lorgeril M., Boissonnat P., Salen P., et al. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients. Transplantation 58 (1994) 193-195
66. Chowienczyk P.J., Kneale B.J., Brett S.E., et al. Lack of effect of Vitamin E on l-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease. Clin Sci 94 (1998) 129-134
67. Wilkinson I.B., Megson I.L., MacCallum H., et al. Oral Vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34 (1999) 690-693
68. Ellis G.R., Anderson R.A., Chirkov Y.Y., et al. Acute effects of Vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 37 (2001) 564-570
69. Schindler T.H., Lewandowski E., Olschewski M., et al. Effect of Vitamin C on platelet aggregation in smokers and non-smokers. Med Klin 97 (2002) 263-269
70. Hamabe A., Takase B., Uehata A., et al. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of Vitamin C. Am J Cardiol 87 (2001) 1154-1159
71. Raitakari O.T., Adams M.R., McCredie R.J., et al. Oral Vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 35 (2000) 1616-1621
72. Gokce N., Keaney Jr. J.F., Frei B., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99 (1999) 3234-3240
73. Duffy S.J., Keaney Jr. J.F., Holbrook M., et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104 (2001) 151-156
74. Duffy S.J., Gokce N., Holbrook M., et al. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 280 (2001) 528-534
75. Singh N., Graves J., Taylor P.D., et al. Effects of a 'healthy' diet and of acute and long-term Vitamin C on vascular function in healthy older subjects. Cardiovasc Res 56 (2002) 118-125
76. Gooderham M.H., Adlercreutz H., Ojala S.T., et al. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 126 (1996) 2000-2006
77. Conquer J.A., Maiani G., Azzini E., et al. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 128 (1998) 593-597
78. Duffy S.J., Vita J.A., Holbrook M., et al. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 1084-1089
79. Hodgson J.M., Puddey I.B., Burke V., et al. Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. Br J Nutr 87 (2002) 141-145
80. Murphy K.J., Chronopoulos A.K., Singh I., et al. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77 (2003) 1466-1473
81. Innes A.J., Kennedy G., McLaren M., et al. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets 14 (2003) 325-327
82. Schramm D.D., Wang J.F., Holt R.R., et al. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73 (2001) 36-40
83. Howes J.B., Tran D., Brillante D., et al. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diab Obes Metab 5 (2003) 325-332
84. Teede H.J., McGrath B.P., DeSilva L., et al. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 23 (2003) 1066-1071
85. Nikander E., Metsa-Heikkila M., Tiitinen A., et al. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 5180-5185
86. Simons L.A., von Konigsmark M., Simons J., et al. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 85 (2000) 1297-1301
87. Squadrito F., Altavilla D., Crisafulli A., et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 114 (2003) 470-476
88. Watts G.F., Playford D.A., Croft K.D., et al. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 45 (2002) 420-426
89. Playford D.A., Watts G.F., Croft K.D., et al. Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes. Atherosclerosis 168 (2003) 169-179
90. de Jongh S., Vissers M.N., Rol P., et al. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 26 (2003) 343-351
91. Westhuyzen J., Cochrane A.D., Tesar P.J., et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. Thorac Cardiovasc Surg 113 (1997) 942-948
92. Kinlay S., Behrendt D., Fang J.C., et al. Long-term effect of combined Vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 43 (2004) 629-634
93. Salonen R.M., Nyyssonen K., Kaikkonen J., et al. Six-year effect of combined Vitamins C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study. Circulation 107 (2003) 947-953
94. Antoniades C., Tousoulis D., Tentolouris C., et al. Effects of antioxidant Vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost 89 (2003) 990-995
95. Tousoulis D., Antoniades C., Tentolouris C., et al. Effects of combined administration of Vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 170 (2003) 261-267
96. Angdin M., Settergren G., Starkopf J., et al. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 314-320
97. Keaney Jr. J.F., Gaziano J.M., Xu A., et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 90 (1993) 11880-11884
98. Keaney Jr. J.F., Guo Y., Cunningham D., et al. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 98 (1996) 386-394
99. Orbe J., Rodriguez J.A., Arias R., et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167 (2003) 45-53
100. Koga T., Kwan P., Zubik L., et al. Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis 176 (2004) 265-272
101. Terasawa Y., Ladha Z., Leonard S.W., et al. Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and Vitamin E. Proc Natl Acad Sci USA 97 (2000) 13830-13834
102. Brasen J.H., Koenig K., Bach H., et al. Comparison of the effects of α-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. Atherosclerosis 163 (2002) 249-259
103. Singh R.B., Shinde S.N., Chopra R.K., et al. Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 148 (2000) 275-282
104. Nakata Y., and Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation 105 (2002) 1485-1490
105. Chen C.C., Hsu J.D., Wang S.F., et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J Agric Food Chem 51 (2003) 5472-5477
106. Kim B.J., Kim Y.K., Park W.H., et al. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. Int Immunopharmacol 3 (2003) 723-734
107. Yamakoshi J., Kataoka S., Koga T., et al. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142 (1999) 139-149
108. Kurosawa T., Itoh F., Nozaki A., et al. Suppressive effects of cacao liquor polyphenols (CLP) on LDL oxidation and the development of atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits. Atherosclerosis 179 (2005) 237-246
109. Febbraio M., Podrez E.A., Smith J.D., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105 (2000) 1049-1056
110. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells. Circulation 102 (2000) 82-87
111. Devaraj S., Hugou I., and Jialal I. α-Tocopherol decreases CD36 expression in human monocyte-derived macrophages. J Lipid Res 42 (2001) 521-527
112. Munteanu A., Zingg J.M., Ogru E., et al. Modulation of cell proliferation and gene expression by α-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem Biophys Res Commun 318 (2004) 311-316
113. Pal S., Thomson A.M., Bottema C.D., et al. α-Tocopherol modulates the low density lipoprotein receptor of human HepG2 cells. Nutr J 2 (2003) 3
114. Chang S.J., Lin J.S., and Chen H.H. α-Tocopherol downregulates the expression of GPIIb promoter in HEL cells. Free Radic Biol Med 28 (2000) 202-207
115. Parola M., Muraca R., Dianzani I., et al. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett 308 (1992) 267-270
116. Li-Weber M., Giaisi M., Treiber M.K., et al. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur J Immunol 32 (2002) 2401-2408
117. Akeson A.L., Woods C.W., Mosher L.B., et al. Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 86 (1991) 261-270
118. Li-Weber M., Weigand M.A., Giaisi M., et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest 110 (2002) 681-690
119. Zapolska-Downar D., Zapolski-Downar A., Markiewski M., et al. Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Commun 274 (2000) 609-615
120. Sabat R., Kolleck I., Witt W., et al. Immunological dysregulation of lung cells in response to Vitamin E deficiency. Free Radic Biol Med 30 (2001) 1145-1153
121. Terasawa Y., Manabe H., Yoshida N., et al. Alpha-tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein. Biofactors 11 (2000) 221-233
122. Kim H.S., Arai H., Arita M., et al. Effect of α-tocopherol status on α-tocopherol transfer protein expression and its messenger RNA level in rat liver. Free Radic Res 28 (1998) 87-92
123. Fruebis J., Silvestre M., Shelton D., et al. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J Lipid Res 40 (1999) 1958-1966
124. Wu D., Hayek M.G., and Meydani S. Vitamin E and macrophage cyclooxygenase regulation in the aged. J Nutr 131 (2001) 382-388
125. Li R.K., Cowan D.B., Mickle D.A., et al. Effect of Vitamin E on human glutathione peroxidase (GSH-PX1) expression in cardiomyocytes. Free Radic Biol Med 21 (1996) 419-426
126. Ueta E., Suzuki E., Nanba E., et al. Regulation of cigarette smoke-induced cytochrome P4501A1 gene expression in osteogenic disorder in shionogi rat liver and in lung by high-dose ascorbic acid dose. Biosci Biotechnol Biochem 65 (2001) 2548-2551
127. Ueta E., Tadokoro Y., Yamamoto T., et al. The effect of cigarette smoke exposure and ascorbic acid intake on gene expression of antioxidant enzymes and other related enzymes in the livers and lungs of Shionogi rats with osteogenic disorders. Toxicol Sci 73 (2003) 339-347
128. Li D.Y., Toland A.E., Boak B.B., et al. Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet 6 (1997) 1021-1028
129. Davidson J.M., LuValle P.A., Zoia O., et al. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J Biol Chem 272 (1997) 345-352
130. Rayment S.J., Shaw J., Woollard K.J., et al. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem Biophys Res Commun 308 (2003) 339-345
131. Wu F., Wilson J.X., and Tyml K. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 285 (2003) 50-56
132. 2 production by alginate, allicin and ascorbic acid in human endothelial cells. Arch Pharm Res 26 (2003) 244-251
133. Saitoh Y., Ouchida R., Kayasuga A., et al. Anti-apoptotic defense of bcl-2 gene against hydroperoxide-induced cytotoxicity together with suppressed lipid peroxidation, enhanced ascorbate uptake, and upregulated Bcl-2 protein. J Cell Biochem 89 (2003) 321-334
134. BelAiba R.S., Djordjevic T., Bonello S., et al. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol Chem 385 (2004) 249-257
135. Tarng D.C., Liu T.Y., and Huang T.P. Protective effect of Vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int 66 (2004) 820-831
136. O'Leary K.A., de Pascual-Tereasa S., Needs P.W., et al. Effect of flavonoids and Vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 551 (2004) 245-254
137. Subbaramaiah K., Chung W.J., Michaluart P., et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273 (1998) 21875-21882
138. Gouedard C., Barouki R., and Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 24 (2004) 5209-5222
139. Jeon S.M., Bok S.H., Jang M.K., et al. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci 69 (2001) 2855-2866
140. Kenny T.P., Keen C.L., Jones P., et al. Pentameric procyanidins isolated from Theobroma cacao seeds selectively downregulate ErbB2 in human aortic endothelial cells. Exp Biol Med 229 (2004) 255-263
141. Nair M.P., Kandaswami C., Mahajan S., et al. The flavonoid, quercetin, differentially regulates Th-1 (IFNδ) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta 1593 (2002) 29-36
142. Lin N., Sato T., Takayama Y., et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 65 (2003) 2065-2071
143. Myhrstad M.C., Carlsen H., Nordstrom O., et al. Flavonoids increase the intracellular glutathione level by transactivation of the δ-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 32 (2002) 386-393
144. Li Y.T., Shen F., Liu B.H., et al. Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells. Acta Pharmacol Sin 24 (2003) 1167-1171
145. Liu J.C., Chen J.J., Chan P., et al. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42 (2003) 1198-1205
146. Carluccio M.A., Siculella L., Ancora M.A., et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: anti-atherogenic properties of Mediterranean diet. phytochemicals. Arterioscler Thromb Vasc Biol 23 (2003) 622-629
147. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol. Br J Pharmacol 126 (1999) 673-680
148. Ma Q., and Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J Biol Chem 277 (2002) 2477-2484
149. Bierhaus A., Chevion S., Chevion M., et al. Advanced glycation end product-induced activation of NF-κB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46 (1997) 1481-1490
150. Zhang W.J., and Frei B. α-Lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15 (2001) 2423-2432
151. Maulik N., Yoshida T., Engelman R.M., et al. Dietary coenzyme Q(10) supplement renders swine hearts resistant to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 278 (2000) 1084-1090
152. Kaliora A.C., Mylona A., Chiou A., et al. Detection and identification of simple phenolics in Pistacia lentiscus resin. J Liq Chrom Rel Technol 27 (2004) 289-300
153. Dedoussis G.V.Z., Kaliora A.C., Psarras S., et al. Anti-atherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis 174 (2004) 293-303
154. Bub A., Barth S., Watzl B., et al. Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in R-allele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet. Eur J Nutr 41 (2002) 237-243